Prof. Chi is currently a chief technician and the deputy director in the Department of Medicine Laboratory at Sun Yat-Sen University (SYSU) Cancer Center, Guangzhou, China. She has been a visiting scholar at the Pathology Department of University of Nebraska Medical Center (UNMC), USA. Prof. Chi has extensive experience and expertise in the field of immunophenotyping of leukemia and lymphoma as well as the study on cellular immune function. She presides over two grants from the National Natural Science Foundation of China and provincial level government, respectively. Prof. Chi was granted a patent and successfully carried out its commercialization. She has published over ten peer-reviewed papers as the first author and corresponding author. As a member of the expert group,Prof. Chi has participated in the formulation of one group standard and 10 expert consensus documents related to flow cytometry detection, as well as four books of academic works. She holds many academic posts, including the standing committee member of the Cell Analysis Professional Committee of the Chinese Society of Biotechnology Engineering and the Flow Cytometry Analysis Diagnosis Expert Committee of the Chinese Association of Integrated Traditional Chinese and Western Medicine for Laboratory Medicine, the vice director of the Flow Cytometry Clinical Application Promotion Group of the Chinese Ethnic Health Association, the chairman of Guangdong Province Immunology Society Committee for the Application and Transformation of New Immunology Technologies, etc.

Immunophenotyping of leukemia and lymphoma; Research on cellular immune function, tumor early  diagnosis and prognostic markers.

1. Lu Y#, Jin Y#, Liu F#, Wang Z#, Zhou W#, Zhang Y, Bai B, Wang Y, Wang Z, Nie M, Luo H, Wei X, Liang C, Guo G, Qiu M, Chen J, Liu Y, Li S, Li Y, Wang F, Wang F, Chi P*, Zhang D*. Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration. Cancer Immunol Immunother. 2024 Sep 5;73(11):220. 

2. Yi-Jun Liu#, Xiao-Hui Li#, Yi-Ling Song#, Yi-Chen Zhou, Rong-Zeng Cai, Pei-Dong Chi*. Evaluation of diagnostic efficacy of NRP-1/CD304 in hematological diseases. Cancer Med, 2023 May;12(10):11284-11292. 

3. Peidong Chi#, Hang Jiang#, Dandan Li#, Jingjing Li, Xizhi Wen, Qiyue Ding, Linbin Chen, Xiaoshi Zhang*, Junqi Huang* and Ya Ding*. An Immune Risk Score Predicts Progression-Free Survival of Melanoma Patients in South China Receiving anti-PD-1 Inhibitor Therapy-a Retrospective Cohort Study Examining 66 Circulating Immune Cell Subsets. Front Immunol, 2022 Dec 7;13:1012673. 

4. Yun Wang#, Shuzhao Chen#, Peidong Chi#, Runcong Nie#, Robert Peter Gale, Hanying Huang, Zhigang Chen, Yanyu Cai, Enping Yan, Xinmei Zhang, Na Zhong, Yang Liang*. Survival prediction optimization of acute myeloid leukaemia based on T-cell function-related genes and plasma proteins. Br J Haematol, 2022 Nov;199(4):572-586.  

5. Shuangpeng Kang#, Qiongli Wu, Jun Huang, Binyan Yang, Changyan Liang, Peidong Chi*, Changyou Wu*. Tissue Resident Memory γδT Cells in Murine Uterus Expressed High Levels of IL-17 Promoting the Invasion of Trophocytes. Front Immunol, 2021 Jan 14;11:588227.   

6. Pei-Dong Chi#, Yi-Jun Liu#, Yu-Hua Huang, Ming-Jie Mao, Yu Wang, Zhi-Ming Li*, Jian Li*. Rinsing Sampling of Core Needle Biopsy for Flow Cytometric Analysis: a Favorable Method for Lymphoma Diagnosis. Cancer Med, 2020 Dec; 9(24):9336-9345. 

7. Xueping Wang#, Minjie Mao#, Shihao Zhu, Shan Xing, Yiling Song, Lin Zhang*, Peidong Chi*. A Novel Nomogram Integrated with Inflammation-Based Factors to Predict the Prognosis of Gastric Cancer Patients. Adv Ther, 2020,37(6):2902-2915. 

8. Mao M#, Wang X#, Sheng H, Liu Y, Zhang L, Dai S*, Chi PD*. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients. BMC Cancer, 2018 Nov 28, 18(1):1178-1191.

9. Chi PD#, Freed NS#, Wake L#, Page C, Smith LM, Amador C, Qureishi HN, Greiner TC, Rodig SJ, Pirruccello SJ, Yuan J*, Fu K*. A simple and effective method for flow cytometric study of lymphoid malignancies using needle core biopsy specimens. Cytometry B Clin Cytom, 2018,94(5):637-643.